ipo
Stage
2017
Founded
1
Investors
About
Deltagen is a biotechnology company focused on drug discovery through genomics and genetics. They aim to develop new therapeutics by identifying and validating novel drug targets.
Explore Deltagen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.